Gender Dysphoria and Gender Incongruence

Introduction

Gender incongruence describes a marked and persistent mismatch between an individual's experienced gender and the sex they were assigned at birth. Gender dysphoria describes the clinically significant distress or functional impairment that may accompany it.¹ The distinction matters: not every person whose gender differs from their birth-assigned sex experiences dysphoria, and it is the distress - not the identity - that constitutes the clinical problem.

ICD-11 made a deliberate and significant change, moving gender incongruence out of the mental and behavioural disorders chapter and into a chapter on conditions related to sexual health. The stated intention was to reduce the stigma of classifying a gender identity as a mental illness, while retaining a diagnostic code so that people can still access healthcare and funding. This mirrors the earlier removal of homosexuality from psychiatric classification, and is a frequently tested point.

Estimates of prevalence vary widely with definition and methodology, but referrals to UK gender services have increased substantially over the past decade. Waiting times for NHS Gender Dysphoria Clinics are currently measured in years, which is itself a significant clinical problem: prolonged waiting is associated with worsening mental health and with people seeking unregulated hormones online without monitoring.

This is a clinically and politically contested area, particularly regarding care for children and young people. What is not contested, and what matters most for practice, is that trans and gender-diverse people experience markedly worse health outcomes and frequently report poor experiences of healthcare - and that respectful, competent general medical care is something every clinician can and should provide regardless of their involvement in gender-specific treatment.

Terminology

Using terminology accurately is a clinical skill, not merely etiquette - getting it wrong is one of the most commonly cited reasons trans people avoid or delay healthcare.

Aetiology

Gender identity is understood to be a complex, multifactorial developmental phenomenon that is not chosen and cannot be changed by external intervention.

• Biological contributions - twin studies suggest a significant heritable component, and prenatal hormone exposure is thought to contribute, though no single determining mechanism has been identified
• Neurobiology - some structural and functional brain differences have been described, though findings are inconsistent and cannot be used diagnostically
• Differences of sex development (DSDs) - conditions such as congenital adrenal hyperplasia and complete androgen insensitivity syndrome have informed understanding of the relative contributions of chromosomes, hormones and rearing to gender identity, but are distinct from gender incongruence and must not be conflated with it
• Not caused by parenting, trauma, social influence or exposure to information about trans people. Conversion or reparative therapy intended to change a person's gender identity is ineffective, associated with significant harm including increased suicidality, and is opposed by every UK medical royal college.

Clinical features

Presentation varies widely. Some people describe lifelong awareness of incongruence from early childhood, while others recognise it in adolescence or adulthood, sometimes after years of suppression.

• A persistent sense that one's gender differs from the sex assigned at birth
• Distress relating to physical sex characteristics - primary (genitals) or secondary (breasts, facial hair, voice, body shape), sometimes with a strong desire to be rid of them
• A desire for the characteristics of the experienced gender
• Distress at being perceived or treated as the birth-assigned gender - being misgendered, called by a previous name, or grouped by sex
• Avoidance behaviours - avoiding swimming, changing rooms, mirrors, intimate relationships, or medical examination
• Chest binding, tucking or padding - common, and clinically relevant because unsafe binding causes rib pain, skin damage and restricted breathing; safe binding advice is a legitimate and useful thing to offer
• Menstruation-related distress in trans men and non-binary people, which is often severe and can be managed with hormonal suppression
• Relief with social transition - many people experience substantial improvement in distress simply from being recognised in their identified gender

Associated mental health

Rates of depression, anxiety, self-harm, suicidality, eating disorders and PTSD are markedly elevated in trans populations. The evidence indicates this is driven substantially by minority stress - discrimination, harassment, family rejection, unemployment, housing insecurity and difficulty accessing care - rather than by gender identity in itself. This distinction is clinically important because it identifies what is actually modifiable: family acceptance and social support are among the strongest protective factors identified.

Assessment

Specialist assessment is carried out by Gender Dysphoria Clinics. The role of the GP or general clinician is to make the referral, provide ongoing general medical care, and address comorbidity - not to assess or validate the person's gender identity.

• History of gender identity development - onset, course, and how the person understands their own experience
• Current distress and functioning, and what would most improve them
• Goals for transition - social, hormonal, surgical, or none; not everyone wants medical intervention, and that is a legitimate outcome
• Mental health assessment, including explicit risk assessment for self-harm and suicidality
• Screen for coexisting conditions - autism, ADHD, depression, anxiety, eating disorders and substance misuse
• Social circumstances - family and peer support, housing, employment, experience of discrimination or violence
• Fertility discussion - gamete storage should be raised before starting hormone therapy, since hormones may permanently impair fertility. This is a common and serious omission.
• Current use of unregulated hormones obtained online - ask non-judgementally; harm reduction and monitoring are far safer than driving the practice underground

Baseline investigations before hormone therapy typically include FBC, U&Es, LFTs, lipids, glucose or HbA1c, and hormone levels, alongside blood pressure and cardiovascular risk assessment.

Management

Care is individualised - there is no single required pathway, and people may pursue some interventions and not others.²

Social transition

Changing name, pronouns, presentation and documentation requires no medical involvement and is fully reversible. It is often the intervention associated with the greatest early reduction in distress. In general practice, patients can change their name and gender marker on their NHS record without a Gender Recognition Certificate, which generates a new NHS number - a process that requires care to avoid losing screening call-and-recall and continuity of records.

Hormone therapy

Hormone therapy is initiated by specialist services, typically with subsequent shared care in primary care once stable. GPs are not expected to initiate treatment independently, but declining to participate in an established shared care arrangement leaves patients without monitoring and is not a neutral act.

Surgery and other interventions

• Chest surgery - mastectomy and chest reconstruction, or breast augmentation
• Genital surgery - vaginoplasty, phalloplasty or metoidioplasty, hysterectomy, orchidectomy
• Facial surgery, hair removal and voice and communication therapy, which is often highly valued and under-provided
• Surgical referral generally follows a period of assessment and, for genital surgery, an established period of hormone therapy and living in the identified gender, in line with service protocols

Children and young people

Care for under-18s in England was reviewed by the Cass Review (2024), which led to substantial service reconfiguration, the closure of the single national service in favour of regional centres, and restriction of puberty blockers for gender incongruence outside research settings. This remains an area of active change, ongoing debate and evolving policy. For exam and practice purposes, the safe position is: refer to the appropriate specialist regional service, do not initiate any hormonal intervention in under-18s, provide mental health support and general medical care, and check current national guidance rather than relying on textbook accounts, which date rapidly.³

Screening and long-term care

This is a practical area that is frequently mishandled, because national screening programmes are usually driven by the gender marker recorded on the electronic record rather than by the organs a person actually has.

• Cervical screening - required if a cervix is present, regardless of recorded gender. Trans men with a male gender marker will not be automatically invited and must be recalled locally.
• Breast screening - trans men who have not had chest surgery retain breast tissue and remain at risk; trans women on long-term oestrogen have some increased risk and may be eligible
• Prostate - trans women retain a prostate after most genital surgery; consider it in relevant urinary symptoms
• Abdominal aortic aneurysm screening - offered to people assigned male at birth, so trans women remain eligible and are frequently missed
• Cardiovascular risk calculators - most are not validated in trans populations; use clinical judgement and document the reasoning
• Bone health - relevant with gonadectomy, and particularly where hormone therapy is interrupted or stopped
• Contraception and sexual health - testosterone is not a contraceptive, and pregnancy remains possible in trans men who retain a uterus and ovaries. This is a critical and commonly missed point.

Red flags

Prognosis

Outcomes following gender-affirming care in adults are generally good, with most studies reporting substantial improvements in dysphoria, quality of life and psychological functioning, and low rates of regret. Regret, where it occurs, is more often linked to surgical complications, loss of social support or unmet expectations than to a change in gender identity itself.

Mental health outcomes remain considerably worse than in the general population, and the evidence attributes this substantially to discrimination, social exclusion, delayed access to care and the effects of very long waiting times. The practical implication is that the elevated distress is largely a function of circumstances rather than of identity - which means prompt referral, respectful care, treatment of comorbidity, and support for family acceptance are genuine, evidence-supported clinical interventions rather than merely courtesies.